| ■ 영문 제목 : Global Gene Therapy Market 2023-2027
|
 | ■ 상품코드 : IRTNTR73059-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 2월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아 태평양, 기타 지역
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,500,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,600,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Technavio사의 본 연구 보고서에 따르면 세계의 유전자 치료 시장 규모가 2022년에서 2027년 사이에 4,613.9백만 달러에 이르며, 예측 기간 동안 연평균 19.91% 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 유전자 치료 시장에 대해서 조사및 분석을 실시하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, Five Force 분석, 치료별 (종양, 중추 신경, 안과, 희소 질환, 기타) 분석, 투여 방법별 (체내, 체외) 분석, 고객 현황, 지역별 현황 (북미, 유럽, 아시아 태평양, 기타 지역, 미국, 영국, 중국, 캐나다, 일본) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 조사 보고서는 Abeona Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc., Amgen Inc., Astellas Pharma Inc., Biogen Inc., bluebird bio Inc., Editas Medicine Inc., ElevateBio, F. Hoffmann La Roche Ltd. 와 같은 기업 정보를 포함하고 있습니다.
・개요
・시장 현황
・시장 규모 예측
・과거 시장 규모
・Five Force 분석
・세계의 유전자 치료 시장 규모 : 치료별
- 종양에 사용되는 유전자 치료의 시장 규모
- 중추 신경에 사용되는 유전자 치료의 시장 규모
- 안과에 사용되는 유전자 치료의 시장 규모
- 희귀 질환에 사용되는 유전자 치료의 시장 규모
- 기타 유전자 치료의 시장 규모
・세계의 유전자 치료 시장 규모 : 투여 방법별
- 체내 투여 유전자 치료의 시장 규모
- 체외 투여 유전자 치료의 시장 규모
・지역별 현황
- 북미의 유전자 치료 시장 규모
- 유럽의 유전자 치료 시장 규모
- 아시아 태평양의 유전자 치료 시장 규모
- 기타 지역의 유전자 치료 시장 규모
- 미국의 유전자 치료 시장 규모
- 영국의 유전자 치료 시장 규모
- 중국의 유전자 치료 시장 규모
- 캐나다의 유전자 치료 시장 규모
- 일본의 유전자 치료 시장 규모
・성장 요인/과제/동향
・기업 현황
・기업 분석
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 유전자 치료 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 유전자 치료 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Gene Therapy Market 2023-2027Technavio has been monitoring the gene therapy market and is forecast to grow by $4613.9 mn during 2022-2027, accelerating at a CAGR of 19.91% during the forecast period. Our report on the gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in special drug designations, benefits associated with gene therapy, and increasing prevalence of chronic diseases.
Technavio’s gene therapy market is segmented as below:
By Therapy Area
• Oncology
• CNS
• Ophthalmology
• Rare diseases
• Others
By Delivery Mode
• In vivo
• Ex vivo
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the growing research in gene therapy for CVDs and orphan diseases as one of the prime reasons driving the gene therapy market growth during the next few years. Also, rapid growth potential in developing economies and rise in clinical pipeline for gene therapy will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the gene therapy market covers the following areas:
• Gene therapy market sizing
• Gene therapy market forecast
• Gene therapy market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene therapy market vendors that include Abeona Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc., Amgen Inc., Astellas Pharma Inc., Biogen Inc., bluebird bio Inc., Editas Medicine Inc., ElevateBio, F. Hoffmann La Roche Ltd., Generation Bio Co., Gilead Sciences Inc., Novartis AG, Orchard Therapeutics Plc, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Sibiono GeneTech Co. Ltd., Syncona Ltd., uniQure NV, and Voyager Therapeutics Inc. Also, the gene therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Therapy Area
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Delivery Mode
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global gene therapy market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global gene therapy market 2017 – 2021 ($ million)
o 4.2 Therapy area Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Therapy area Segment 2017 – 2021 ($ million)
o 4.3 Delivery mode Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Delivery mode Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Therapy Area
o 6.1 Market segments
o Exhibit 30: Chart on Therapy Area – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapy Area – Market share 2022-2027 (%)
o 6.2 Comparison by Therapy Area
o Exhibit 32: Chart on Comparison by Therapy Area
o Exhibit 33: Data Table on Comparison by Therapy Area
o 6.3 Oncology – Market size and forecast 2022-2027
o Exhibit 34: Chart on Oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oncology – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
o 6.4 CNS – Market size and forecast 2022-2027
o Exhibit 38: Chart on CNS – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on CNS – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on CNS – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on CNS – Year-over-year growth 2022-2027 (%)
o 6.5 Ophthalmology – Market size and forecast 2022-2027
o Exhibit 42: Chart on Ophthalmology – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Ophthalmology – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Ophthalmology – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Ophthalmology – Year-over-year growth 2022-2027 (%)
o 6.6 Rare diseases – Market size and forecast 2022-2027
o Exhibit 46: Chart on Rare diseases – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Rare diseases – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Rare diseases – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Rare diseases – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Therapy Area
o Exhibit 54: Market opportunity by Therapy Area ($ million)
• 7 Market Segmentation by Delivery Mode
o 7.1 Market segments
o Exhibit 55: Chart on Delivery Mode – Market share 2022-2027 (%)
o Exhibit 56: Data Table on Delivery Mode – Market share 2022-2027 (%)
o 7.2 Comparison by Delivery Mode
o Exhibit 57: Chart on Comparison by Delivery Mode
o Exhibit 58: Data Table on Comparison by Delivery Mode
o 7.3 In vivo – Market size and forecast 2022-2027
o Exhibit 59: Chart on In vivo – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on In vivo – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on In vivo – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on In vivo – Year-over-year growth 2022-2027 (%)
o 7.4 Ex vivo – Market size and forecast 2022-2027
o Exhibit 63: Chart on Ex vivo – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Ex vivo – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Ex vivo – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Ex vivo – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Delivery Mode
o Exhibit 67: Market opportunity by Delivery Mode ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 69: Chart on Market share by geography 2022-2027 (%)
o Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 71: Chart on Geographic comparison
o Exhibit 72: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 73: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 81: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 89: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 93: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 101: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 105: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 109: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Abeona Therapeutics Inc.
o Exhibit 116: Abeona Therapeutics Inc. – Overview
o Exhibit 117: Abeona Therapeutics Inc. – Product / Service
o Exhibit 118: Abeona Therapeutics Inc. – Key offerings
o 12.4 Amgen Inc.
o Exhibit 119: Amgen Inc. – Overview
o Exhibit 120: Amgen Inc. – Product / Service
o Exhibit 121: Amgen Inc. – Key offerings
o 12.5 Astellas Pharma Inc.
o Exhibit 122: Astellas Pharma Inc. – Overview
o Exhibit 123: Astellas Pharma Inc. – Product / Service
o Exhibit 124: Astellas Pharma Inc. – Key offerings
o 12.6 Biogen Inc.
o Exhibit 125: Biogen Inc. – Overview
o Exhibit 126: Biogen Inc. – Product / Service
o Exhibit 127: Biogen Inc. – Key offerings
o 12.7 bluebird bio Inc.
o Exhibit 128: bluebird bio Inc. – Overview
o Exhibit 129: bluebird bio Inc. – Product / Service
o Exhibit 130: bluebird bio Inc. – Key offerings
o 12.8 ElevateBio
o Exhibit 131: ElevateBio – Overview
o Exhibit 132: ElevateBio – Product / Service
o Exhibit 133: ElevateBio – Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 134: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 135: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 136: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 137: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 138: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 Generation Bio Co.
o Exhibit 139: Generation Bio Co. – Overview
o Exhibit 140: Generation Bio Co. – Product / Service
o Exhibit 141: Generation Bio Co. – Key offerings
o 12.11 Gilead Sciences Inc.
o Exhibit 142: Gilead Sciences Inc. – Overview
o Exhibit 143: Gilead Sciences Inc. – Product / Service
o Exhibit 144: Gilead Sciences Inc. – Key news
o Exhibit 145: Gilead Sciences Inc. – Key offerings
o 12.12 Novartis AG
o Exhibit 146: Novartis AG – Overview
o Exhibit 147: Novartis AG – Business segments
o Exhibit 148: Novartis AG – Key offerings
o Exhibit 149: Novartis AG – Segment focus
o 12.13 Orchard Therapeutics Plc
o Exhibit 150: Orchard Therapeutics Plc – Overview
o Exhibit 151: Orchard Therapeutics Plc – Product / Service
o Exhibit 152: Orchard Therapeutics Plc – Key offerings
o 12.14 Poseida Therapeutics Inc.
o Exhibit 153: Poseida Therapeutics Inc. – Overview
o Exhibit 154: Poseida Therapeutics Inc. – Product / Service
o Exhibit 155: Poseida Therapeutics Inc. – Key offerings
o 12.15 Sibiono GeneTech Co. Ltd.
o Exhibit 156: Sibiono GeneTech Co. Ltd. – Overview
o Exhibit 157: Sibiono GeneTech Co. Ltd. – Product / Service
o Exhibit 158: Sibiono GeneTech Co. Ltd. – Key offerings
o 12.16 uniQure NV
o Exhibit 159: uniQure NV – Overview
o Exhibit 160: uniQure NV – Product / Service
o Exhibit 161: uniQure NV – Key offerings
o 12.17 Voyager Therapeutics Inc.
o Exhibit 162: Voyager Therapeutics Inc. – Overview
o Exhibit 163: Voyager Therapeutics Inc. – Product / Service
o Exhibit 164: Voyager Therapeutics Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 165: Inclusions checklist
o Exhibit 166: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 167: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 168: Research methodology
o Exhibit 169: Validation techniques employed for market sizing
o Exhibit 170: Information sources
o 13.5 List of abbreviations
o Exhibit 171: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Therapy Area
Exhibits6: Executive Summary – Chart on Market Segmentation by Delivery Mode
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global gene therapy market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Therapy area Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Delivery mode Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Therapy Area – Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy Area – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy Area
Exhibits33: Data Table on Comparison by Therapy Area
Exhibits34: Chart on Oncology – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oncology – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on CNS – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on CNS – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on CNS – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on CNS – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Ophthalmology – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Ophthalmology – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Ophthalmology – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Ophthalmology – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Rare diseases – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Rare diseases – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Rare diseases – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Rare diseases – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Therapy Area ($ million)
Exhibits55: Chart on Delivery Mode – Market share 2022-2027 (%)
Exhibits56: Data Table on Delivery Mode – Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Delivery Mode
Exhibits58: Data Table on Comparison by Delivery Mode
Exhibits59: Chart on In vivo – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on In vivo – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on In vivo – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on In vivo – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Ex vivo – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Ex vivo – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Ex vivo – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Ex vivo – Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Delivery Mode ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share by geography 2022-2027 (%)
Exhibits70: Data Table on Market share by geography 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity by geography ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Abeona Therapeutics Inc. – Overview
Exhibits117: Abeona Therapeutics Inc. – Product / Service
Exhibits118: Abeona Therapeutics Inc. – Key offerings
Exhibits119: Amgen Inc. – Overview
Exhibits120: Amgen Inc. – Product / Service
Exhibits121: Amgen Inc. – Key offerings
Exhibits122: Astellas Pharma Inc. – Overview
Exhibits123: Astellas Pharma Inc. – Product / Service
Exhibits124: Astellas Pharma Inc. – Key offerings
Exhibits125: Biogen Inc. – Overview
Exhibits126: Biogen Inc. – Product / Service
Exhibits127: Biogen Inc. – Key offerings
Exhibits128: bluebird bio Inc. – Overview
Exhibits129: bluebird bio Inc. – Product / Service
Exhibits130: bluebird bio Inc. – Key offerings
Exhibits131: ElevateBio – Overview
Exhibits132: ElevateBio – Product / Service
Exhibits133: ElevateBio – Key offerings
Exhibits134: F. Hoffmann La Roche Ltd. – Overview
Exhibits135: F. Hoffmann La Roche Ltd. – Business segments
Exhibits136: F. Hoffmann La Roche Ltd. – Key news
Exhibits137: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits139: Generation Bio Co. – Overview
Exhibits140: Generation Bio Co. – Product / Service
Exhibits141: Generation Bio Co. – Key offerings
Exhibits142: Gilead Sciences Inc. – Overview
Exhibits143: Gilead Sciences Inc. – Product / Service
Exhibits144: Gilead Sciences Inc. – Key news
Exhibits145: Gilead Sciences Inc. – Key offerings
Exhibits146: Novartis AG – Overview
Exhibits147: Novartis AG – Business segments
Exhibits148: Novartis AG – Key offerings
Exhibits149: Novartis AG – Segment focus
Exhibits150: Orchard Therapeutics Plc – Overview
Exhibits151: Orchard Therapeutics Plc – Product / Service
Exhibits152: Orchard Therapeutics Plc – Key offerings
Exhibits153: Poseida Therapeutics Inc. – Overview
Exhibits154: Poseida Therapeutics Inc. – Product / Service
Exhibits155: Poseida Therapeutics Inc. – Key offerings
Exhibits156: Sibiono GeneTech Co. Ltd. – Overview
Exhibits157: Sibiono GeneTech Co. Ltd. – Product / Service
Exhibits158: Sibiono GeneTech Co. Ltd. – Key offerings
Exhibits159: uniQure NV – Overview
Exhibits160: uniQure NV – Product / Service
Exhibits161: uniQure NV – Key offerings
Exhibits162: Voyager Therapeutics Inc. – Overview
Exhibits163: Voyager Therapeutics Inc. – Product / Service
Exhibits164: Voyager Therapeutics Inc. – Key offerings
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations
|
| ※본 조사보고서 [세계의 유전자 치료 시장 (2023년~2027년)] (코드 : IRTNTR73059-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 유전자 치료 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요! 세계의 유전자 치료 시장 (2023년~2027년)
